Efficacy of echinocandins against murine infections by Diutina (Candida) rugosa

被引:4
作者
Sanchis, Marta [1 ]
Sutton, Deanna A. [2 ]
Wiederhold, Nathan P. [2 ]
Guarro, Josep [1 ]
Capilla, Javier [1 ]
机构
[1] Univ Rovira & Virgili, IISPV, Unitat Microbiol, Fac Med & Ciencies Salut, Tarragona, Spain
[2] Univ Texas Hlth Sci Ctr San Antonio, Fungus Testing Lab, San Antonio, TX 78229 USA
关键词
Anidulafungin; Caspofungin; Diutina rugosa; Antifungals; Fungal infections; Animal model; AMPHOTERICIN-B; TIME-KILL; SPECIES COMPLEX; CASPOFUNGIN; ANIDULAFUNGIN; MICAFUNGIN; GUILLIERMONDII; PARAPSILOSIS; VORICONAZOLE; NEORUGOSA;
D O I
10.1016/j.diagmicrobio.2016.05.014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Echinocandins are recommended as a first-line therapy for invasive candidiasis. Candida rugosa was recently transferred to the new genus Diutina. We have determined the in vitro killing kinetics of two echinocandins, anidulafungin, and caspofungin and their in vivo efficacy, administering doses of 5 or 10 mg/kg, and 1 or 5 mg/kg, respectively against 2 clinical strains of D. rugosa. Both drugs showed a fungicidal concentration dependent activity and, in a neutropenic murine model of disseminated infection, were able to reduce tissue burden and to prolong survival of mice. These results suggest that both echinocandins could be useful to treat infections by this fungus when isolates show minimal inhibitory concentrations within the range of susceptibility for both drugs. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:61 / 65
页数:5
相关论文
共 29 条
  • [1] In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species
    Andes, D.
    Diekema, D. J.
    Pfaller, M. A.
    Bohrmuller, J.
    Marchillo, K.
    Lepak, A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (06) : 2497 - 2506
  • [2] ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of rare invasive yeast infections
    Arendrup, M. C.
    Boekhout, T.
    Akova, M.
    Meis, J. F.
    Cornely, O. A.
    Lortholary, O.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 76 - 98
  • [3] Effects of caspofungin against Candida guilliermondii and Candida parapsilosis
    Barchiesi, Francesco
    Spreghini, Elisabetta
    Tomassetti, Serena
    Della Vittoria, Agnese
    Arzeni, Daniela
    Manso, Esther
    Scalise, Giorgio
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (08) : 2719 - 2727
  • [4] Candida rugosa: a possible emerging cause of candidaemia in trauma patients
    Behera, B.
    Singh, R. I.
    Xess, I.
    Mathur, P.
    Hasan, F.
    Misra, M. C.
    [J]. INFECTION, 2010, 38 (05) : 387 - 393
  • [5] Benjamin S, 1998, YEAST, V14, P1069, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1069::AID-YEA303>3.3.CO
  • [6] 2-B
  • [7] Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods
    Canton, Emilia
    Peman, Javier
    Hervas, David
    Espinel-Ingroff, Ana
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (04) : 864 - 868
  • [8] In Vitro Activities of Echinocandins against Candida krusei Determined by Three Methods: MIC and Minimal Fungicidal Concentration Measurements and Time-Kill Studies
    Canton, Emilia
    Peman, Javier
    Valentin, Amparo
    Espinel-Ingroff, Ana
    Gobernado, Miguel
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (07) : 3108 - 3111
  • [9] Animal models: an important tool in mycology
    Capilla, Javier
    Clemons, Karl V.
    Stevens, David A.
    [J]. MEDICAL MYCOLOGY, 2007, 45 (08) : 657 - 684
  • [10] Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis
    Clemons, KV
    Espiritu, M
    Parmar, R
    Stevens, DA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (12) : 4867 - 4875